9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

Grants

Funding Acknowledgements

This work was supported by the following sources - ABCFS: National Health and Medical Research Council of Australia, the New South Wales Cancer Council; the Victorian Health Promotion Foundation (Australia); the United States (US) National Cancer Institute, NIH [RFA CA 06 503]; and through cooperative agreements with members of the Breast Cancer Family Registry (CFR) and principal investigators. The University of Melbourne [U01 CA69638] contributed data to this study. ABCS: Dutch Cancer Society [NKI 2001-2423, 2007-3839] and Dutch National Genomics Initiative. ACP: Breast Cancer Research Trust, UK. BBCC: ELAN program of the University Hospital of Erlangen. BBCS: Cancer Research UK [C150/A5660 and C1178/A3947]; Break through Breast Cancer; and NHS funding to the NIHR Biomedical Research Centre and the National Cancer Research Network (NCRN). H. Warren is funded by the UK Medical Research Council [G0801414]. BCAC: Cancer Research UK [C1287/A10118, C1287/A12014] and the European Community's Seventh Framework Programme under grant agreement no. 223175 (HEALTH-F2-2009-223175) (COGS). BCAC meetings have been funded by the European Union COST program [BM0606]. BIGGS: NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London [to E.J. Sawyer]; Oxford Biomedical Research Centre (to I. Tomlinson]. BSUCH: Helmholtz Society; German Cancer Research Center; and Dietmar-Hopp Foundation. CECILE: Fondation de France [2004012618, 2007005156]; Institut National du Cancer (INCa) [2007-1/SPC2, 2008-1-CP-4, 2009-1-SHS/SP-04]; Association pour la Recherche contre le Cancer (ARC) [2008-1-CP-4]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES) [ST-2005-003, EST2008/1/26, and VS-2009-21]; Ligue contre le Cancer Grand Ouest; and Agence Nationale de la Recherche (ANR) [00047-05]. CGPS: Herlev Hospital; Chief Physician Johan Boserup; and Lise Boserup's Fund. CNIO-BCS: Genome Spain Foundation; the Red Tematica de Investigacion Cooperativa en Cancer and grants from the Asociacion Espanola Contra el Cancer; and the Fondo de Investigacion Sanitario [PI081583, PI081120]. CTS: California Breast Cancer Act of 1993; NIH [R01 CA77398]; the Lon V Smith Foundation [LVS39420]; and the California Breast Cancer Research Fund [contract 97-10500]. Collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer-reporting program mandated by California Health and Safety Code Section 103885. ESTHER: Baden-Wurttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study that was supported by a grant from the Deutsche Krebshilfe (German Cancer Aid). GESBC: Deutsche Krebshilfe e.V. [70492]; and genotyping in part by the state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm [P.685]. GC-HBOC: Deutsche Krebshilfe [107054]; the Dietmar-Hopp Foundation; the Helmholtz society; and the German Cancer Research Centre (DKFZ). GENICA: Federal Ministry of Education and Research (BMBF) Germany [01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114]; Robert Bosch Foundation, Stuttgart; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg; Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany. HABCS: Rudolf Bartling Foundation.HEBCS: Helsinki University Central Hospital Research Fund, Academy of Finland [132473]; Finnish Cancer Society; Nordic Cancer Union; and Sigrid Juselius Foundation. HMBCS: Hannelore Munke Stipend [to N. Bogdanova]. HUBCS: German Federal Ministry for Research and Education [RUS 08/017]. KARBAC: Swedish Cancer Society; Stockholm Cancer Society; and Gustav V Jubilee Foundation. KBCP: Finnish Cancer Society; Academy of Finland [127220], special Government Funding (EVO) of Kuopio University Hospital [5654113, 5501]; and strategic funding from the University of Eastern Finland. KConFab-AOCS: National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Councils of New South Wales, Victoria, Tasmania and South Australia; and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up Study was funded by the NHMRC [145684, 288704, 454508]. Financial support for the AOCS was provided by the US Army Medical Research and Materiel Command [DAMD17-01-1-0729], the Cancer Council of Tasmania and Cancer Foundation of Western Australia and the NHMRC [199600]. G. Chenevix-Trench and P. Webb are supported by the NHMRC. LMBC: 'Stichting tegen Kanker' [232-2008, 196-2010]. MARIE: Deutsche Krebshilfe e.V. [70-2892-BR 1]; Hamburg Society; German Cancer Research Center; and the genotype work in part by the Federal Ministry of Education and Research (BMBF) Germany [01KH0402]. MBCSG: Ministero della Salute (Extraordinary National Cancer Program 2006 "Alleanza contro il Cancro", and "Progetto Tumori Femminili") (to P. Radice); Ministero dell'Universita e Ricerca (RBLAO3-BETH; to P. Radice); Fondazione Italiana per la Ricerca sul Cancro (Special Project "Hereditary tumors"); Associazione Italiana per la Ricerca sul Cancro (4017; to P. Peterlongo) and by funds from Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects "5 x 1000"). MCBCS: NIH [CA122340]; Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; the Komen Foundation for the Cure; and the Breast Cancer Research Foundation (BCRF). MCCS: Australian National Health and Medical Research Council [209057, 251533, 396414, 504711], with infrastructure support provided by the Cancer Council Victoria, and cohort recruitment partly funded by VicHealth. NC-BCFR: US National Cancer Institute, NIH [RFA-CA-06-503] and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Cancer Care Ontario [U01 CA69467], the Cancer Prevention Institute of California [U01 CA69417], and The University of Melbourne [U01 CA69638]. Samples from the NC-BCFR were processed and distributed by the Coriell Institute for Medical Research. OBCS: Finnish Cancer Foundation; Academy of Finland; University of Oulu; and Oulu University Hospital. OFBCR: US National Cancer Institute, NIH [RFA-CA-06503] and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Cancer Care Ontario [U01 CA69467], Northern California Cancer Center [U01 CA69417], and University of Melbourne [U01 CA69638] and by Cancer Care Ontario. ORIGO: Dutch Cancer Society [RUL 1997-1505]; and Biobanking and Biomolecular Resources Research Infrastructure [BBMRI-NL CP16]. RBCS: Dutch Cancer Society [DDHK 2004-3124, DDHK 2009-4318]. SASBAC: NIH [RO1 CA58427] [to P. Hillemanns and J.Liu]; and the Agency for Science, Technology and Research (A *STAR; Singapore). SBCS: Yorkshire Cancer Research; and Breast Cancer Campaign. SEARCH: Programme grant from Cancer Research UK [C490/A10124]. UCIBCS: US NIH [CA58860, CA92044] and the Lon V Smith Foundation [LVS39420]. UKBGS: Breakthrough Breast Cancer.